For simple transfers without intellectual property, the NIH recommends a simple matching agreement. For materials that can be patented or for which increased protection is desired, the Uniform Biological Material Transfer Agreement (UBMTA) can be used. Many U.S. educational institutions have signed the UBMTA Masteragrement. [2] AUTM (formerly the Association of University Technology Managers) serves as a repository for UBMTA`s original master`s contracts and keeps the list of signatories. [3] UBMTA signatories must only sign a letter of execution containing the details of each transfer, since they have already agreed to all the terms of the master contract. There are a number of scenarios in which an MTA can help clarify the conditions associated with moving or using associated samples and data. This may include: 1. exporting or internationally transferring associated samples and data;2) national transfer of samples and data associated with a separate corporation (or, in some cases, perhaps even for different parts of the same corporation); 3) Determining the final use or subsequent distribution of samples and related data released for purpose, but with the potential for additional uses;4. subject to specific rules or rules or when a third party, for example.

B a government authority such as a Ministry of Health, is (or should be) involved;5. If the moving material has a potentially significant intrinsic value (either the material itself, or the possibility of using it in other processes or for product development); and six. Under broader agreements, such as research protocols and bilateral agreements, such as Z.B. MTAs can be very simple documents or more complex legal arrangements. The degree of detail can be determined by the potential commercial value of the transferred material and the intended uses on which it is based. A discussion on how these agreements might match the details of the transfer, see: Use and misuse of material transfer agreements: Lessons in proportionality of research, repositories and the Litigation A Material Transfer Agreement (MTA) is a contract for the transfer of equipment between two parties. It defines the rights of the supplier and recipient with respect to materials and derivatives. MTAs can help ensure a common understanding of what is shared, for what purpose and how to use it. STDs regularly regulate the transmission of biological material, such as samples, but can also cover associated data, such as metadata or the donor`s clinical condition. For more information, see: Material Transfer Agreements: a tool for international cooperation for single use. In the event of a public health emergency, it will be important to ensure that samples and associated data can be moved, accessed and used for many important purposes, including identifying and characterizing the officer responsible, diagnostic objectives, clinical decision-making, epidemiology and the development or validation of diagnostic tools. Given the emergency context, simple and transparent measures are desirable to protect the interests of all parties.

This may include provisions to protect the supplier who sent the samples in good faith to a home. During the public consultation on this instrument, several informed people found that there was no comprehensive international public health framework that regulates access to samples and related data from non-flu diseases. There were widely differing views on the appropriateness or feasibility of developing such a framework. In its absence and given that a rapid response to a public health emergency may depend on the ability to move relevant samples and associated data from one location to another. The transfer of these samples and associated data should be as simple and transparent as possible, while protecting the interests of the owners of the samples and associated data. The instrument is in line with the views of many involved in the development of the importance of